| Cigna EviCore | MOL.TS.194.A: Liquid Biopsy Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.197.A: Lynch Syndrome Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.206.A: MUTYH Associated Polyposis Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.209.A: Non-Invasive Prenatal Screening | 2026-01-01 |
| Cigna EviCore | MOL.TS.215.A: PCA3 Testing for Prostate Cancer | 2026-01-01 |
| Cigna EviCore | MOL.TS.217.A: Prader-Willi Syndrome Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.223.A: PTEN Hamartoma Tumor Syndromes Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.225.A: Spinal Muscular Atrophy Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.228.A: Tissue of Origin Testing for Cancer of Unknown Primary | 2026-01-01 |
| Cigna EviCore | MOL.TS.230.C: Somatic Mutation Testing | 2026-01-01 |